HC Wainwright Reiterates Neutral Rating for LAVA Therapeutics (NASDAQ:LVTX)
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report)‘s stock had its “neutral” rating restated by HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $1.50 target price on the stock. HC Wainwright’s target price indicates a potential upside of 20.00% from the stock’s current price. A number of other analysts have also […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report)‘s stock had its “neutral” rating restated by HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $1.50 target price on the stock. HC Wainwright’s target price indicates a potential upside of 20.00% from the stock’s current price. A number of other analysts have also […]
